International Cardio Corporation

Selected news for the company - International Cardio Corporation, collected since 8/2019. We are still establishing shared news links for this company.

Please provide a valid email address.
Shares Healthcare News With (link):
Other Healthcare Entities

Selected Headines

Date Headline (link) Source Relevant Snippet
8/16/2019 International Cardio begins first-in-human trial of its high-intensity ultrasound system vascularnews.com International Cardio Corporation (ICC) announced that it has achieved the first human use of its high-intensity focused ultrasound (HIFU) system to designed to treat peripheral vascular disease (PVD). The Minneapolis-based company said its HIFU Synthesiser system is undergoing a 15-patient safety study in The Netherlands to investigate its feasibility and safety for the treatment of atherosclerotic plaques. The system uses high-intensity ultrasound to noninvasively treat vulnerable ...
8/16/2019 International Cardio begins first-in-human trial of its high-intensity ultrasound system interventionalnews.com International Cardio begins first-in-human trial of its high-intensity ultrasound system 16th August 2019 75 International Cardio Corporation (ICC) announced that it has achieved the first human use of its high-intensity focused ultrasound (HIFU) system to designed to treat peripheral vascular disease (PVD). The Minneapolis-based company said its HIFU Synthesiser system is undergoing a 15-patient safety study in The Netherlands to investigate its feasibility and ...
8/10/2019 International Cardio begins first-in-human trial medicaldesignandoutsourcing.com International Cardio Corporation (ICC) announced this week that it has achieved the first human use of its high-intensity focused ultrasound system to designed to treat peripheral vascular disease (PVD). The Minneapolis-based company said its HIFU Synthesizer system is undergoing a 15-patient safety study in the Netherlands.The system uses high-intensity ultrasound to noninvasively treat vulnerable and occlusive plaques in peripheral arteries to reduce stroke mortality and improve ...
8/9/2019 International Cardio Corporation Achieves First Human Use of Its Noninvasive HIFU Treatment for Peripheral Vascular Disease Tech dot MN ... disability and reduction of quality of life from symptoms related to PVD. This Safety Study is the first step towards achievement of CE mark and FDA approval for ICC’s noninvasive treatment of PVD. About International Cardio Corporation ICC was founded in 2007 to research and demonstrate the potential of High Intensity Focused Ultrasound (HIFU) to both noninvasively target and treat PVD. Since 2009, ICC has sponsored proof of concept studies ...
8/8/2019 International Cardio Corporation Achieves First Human Use of Its Noninvasive HIFU Treatment for PVD | Business & Finance | heraldchronicle.com Business Wire ... disability and reduction of quality of life from symptoms related to PVD. This Safety Study is the first step towards achievement of CE mark and FDA approval for ICC’s noninvasive treatment of PVD. About International Cardio Corporation ICC was founded in 2007 to research and demonstrate the potential of High Intensity Focused Ultrasound (HIFU) to both noninvasively target and treat PVD. Since 2009, ICC has sponsored proof of concept studies ...
8/8/2019 International Cardio Corporation Achieves First Human Use of Its Noninvasive HIFU Treatment for PVD wapakdailynews.com ... disability and reduction of quality of life from symptoms related to PVD. This Safety Study is the first step towards achievement of CE mark and FDA approval for ICC’s noninvasive treatment of PVD. About International Cardio Corporation ICC was founded in 2007 to research and demonstrate the potential of High Intensity Focused Ultrasound (HIFU) to both noninvasively target and treat PVD. Since 2009, ICC has sponsored proof of concept studies ...
8/8/2019 International Cardio Corporation Achieves First Human Use of Its Noninvasive HIFU Treatment for PVD sys-con.com ... disability and reduction of quality of life from symptoms related to PVD. This Safety Study is the first step towards achievement of CE mark and FDA approval for ICC’s noninvasive treatment of PVD. About International Cardio Corporation ICC was founded in 2007 to research and demonstrate the potential of High Intensity Focused Ultrasound (HIFU) to both noninvasively target and treat PVD. Since 2009, ICC has sponsored proof of concept studies ...
8/8/2019 International Cardio Corporation Achieves First Human Use of Its Noninvasive HIFU Treatment for PVD BioSpace International Cardio Corporation Achieves First Human Use of Its Noninvasive HIFU Treatment for PVD Published: Aug 08, 2019 MINNEAPOLIS--( BUSINESS WIRE )-- International Cardio Corporation (ICC) announced today that it has achieved the first human use milestone of its HIFU Synthesizer™, a therapeutic ultrasound system designed to noninvasively treat vulnerable and occlusive plaques in peripheral arteries. The first of a fifteen patient Safety Study in the Netherlands, this achievement supports the ...